FDA clears Emergent’s nasal spray for opioid overuse to sell at pharmacies
US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.
Drugs
Health
Pharma